HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 203 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,308,690 | +52.9% | 41,900 | +22.9% | 0.12% | +106.8% |
| Q3 2022 | $1,510,000 | -40.1% | 34,100 | -34.2% | 0.06% | -45.4% |
| Q1 2022 | $2,519,000 | +234.1% | 51,786 | +192.9% | 0.11% | +129.8% |
| Q4 2021 | $754,000 | -63.9% | 17,680 | -67.5% | 0.05% | -68.9% |
| Q3 2021 | $2,087,000 | +150.8% | 54,430 | +84.7% | 0.15% | +88.8% |
| Q2 2021 | $832,000 | +235.5% | 29,475 | +293.0% | 0.08% | +247.8% |
| Q1 2021 | $248,000 | – | 7,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $496,847,000 | 95.45% |
| Vivo Capital, LLC | 3,400,261 | $150,598,000 | 16.63% |
| Nan Fung Group Holdings Ltd | 510,978 | $22,631,000 | 14.44% |
| venBio Partners LLC | 1,125,673 | $49,856,000 | 11.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 264,500 | $11,715,000 | 3.76% |
| ASHFORD CAPITAL MANAGEMENT INC | 490,768 | $21,736,000 | 3.32% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 636,485 | $28,190,000 | 2.79% |
| Octagon Capital Advisors LP | 243,500 | $10,785,000 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 310,000 | $13,730,000 | 1.68% |
| Lisanti Capital Growth, LLC | 248,070 | $10,987,000 | 1.47% |